These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa. Schwartz RH Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576 [TBL] [Abstract][Full Text] [Related]
8. Generic vs. proprietary otic drops. Hotmes WF; Cunningham JD; Alford E Trans Pa Acad Ophthalmol Otolaryngol; 1989; 41():859-60. PubMed ID: 2561028 [No Abstract] [Full Text] [Related]
9. Ototoxicity of ear drops: a clinical perspective. Linder TE; Zwicky S; Brändle P Am J Otol; 1995 Sep; 16(5):653-7. PubMed ID: 8588672 [TBL] [Abstract][Full Text] [Related]
10. Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis. Dohar JE; Roland P; Wall GM; McLean C; Stroman DW Curr Med Res Opin; 2009 Feb; 25(2):287-91. PubMed ID: 19192973 [TBL] [Abstract][Full Text] [Related]
11. Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials. Cantrell HF; Lombardy EE; Duncanson FP; Katz E; Barone JS South Med J; 2004 May; 97(5):465-71. PubMed ID: 15180022 [TBL] [Abstract][Full Text] [Related]
12. Tympanostomy tubes and otic drops. Meyerhoff WL; Morizono T; Wright CG; Shaddock LC; Shea DA; Sikora MA Laryngoscope; 1983 Aug; 93(8):1022-7. PubMed ID: 6308368 [TBL] [Abstract][Full Text] [Related]
15. Skin testing after anaphylaxis to a topical Neosporin preparation. Schroer BC; Fox CC; Hauswirth DW Ann Allergy Asthma Immunol; 2008 Oct; 101(4):444. PubMed ID: 18939736 [No Abstract] [Full Text] [Related]
16. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children. Rahman A; Rizwan S; Waycaster C; Wall GM Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194 [TBL] [Abstract][Full Text] [Related]
17. Is there an ototoxicity risk from Cortisporin and comparable otic suspensions? Distortion-product otoacoustic emission findings. Berenholz LP; Rossi DL; Lippy WH; Burkey JM Ear Nose Throat J; 2012 Mar; 91(3):106-35. PubMed ID: 22430335 [TBL] [Abstract][Full Text] [Related]
18. Controlled multicenter study on chronic suppurative otitis media treated with topical applications of ciprofloxacin 0.2% solution in single-dose containers or combination of polymyxin B, neomycin, and hydrocortisone suspension. Miró N Otolaryngol Head Neck Surg; 2000 Nov; 123(5):617-23. PubMed ID: 11077352 [TBL] [Abstract][Full Text] [Related]
19. Antibiotics and endodontics. Leblanc D Aust Dent J; 1990 Dec; 35(6):551. PubMed ID: 2090089 [No Abstract] [Full Text] [Related]
20. [Efficiency of otoph and polydex ear drops in otitis treatment]. Luchikhin LA; Magomedov MM; Gorbacheva VA Vestn Otorinolaringol; 1999; (4):32-4. PubMed ID: 10453233 [No Abstract] [Full Text] [Related] [Next] [New Search]